Literature DB >> 17018027

Down-regulation of WNK1 protein kinase in neural progenitor cells suppresses cell proliferation and migration.

Xutong Sun1, Luoyi Gao, Robert K Yu, Guichao Zeng.   

Abstract

WNK1, a Ser/Thr protein kinase, is widely expressed in many tissues. Its biological functions are largely unknown. Disruption of the WNK1 gene in mice leads to embryonic lethality at day 13, implicating a critical role of WNK1 in embryonic development. To investigate this potential function, we used antisense strategy to knock down the expression of WNK1 in a mouse neural progenitor cell line, C17.2. Down-regulation of WNK1 in C17.2 cells greatly reduced cell growth. Addition of epidermal growth factor (EGF), a mitogen for C17.2 cells, had no effect on growth. The WNK1-knockdown cells showed a flat and rounded morphology, characteristic of the immature and non-differentiated phenotype of the progenitor cells; this was further demonstrated by immunostaining for the progenitor and neuronal markers. Migration of the WNK1-knockdown C17.2 cells was reduced as tested in culture dishes or Matrigel-covered chambers. Moreover, activation of extracellular signal-regulated kinase (ERK1)/2 and ERK5 by EGF in the WNK1-knockdown cells was suppressed. These results demonstrate a novel function of WNK1 in proliferation, migration, and differentiation of neural progenitor cells, likely by mechanisms involving activation of the mitogen-activated protein (MAP) kinase ERK1/2 and/or ERK5 pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17018027     DOI: 10.1111/j.1471-4159.2006.04159.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  32 in total

1.  Actions of the protein kinase WNK1 on endothelial cells are differentially mediated by its substrate kinases OSR1 and SPAK.

Authors:  Hashem A Dbouk; Lauren M Weil; G K Sachith Perera; Michael T Dellinger; Gray Pearson; Rolf A Brekken; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-31       Impact factor: 11.205

2.  Downregulation of ACSM3 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma.

Authors:  Hao-Yu Ruan; Chen Yang; Xue-Mei Tao; Jia He; Ting Wang; Hui Wang; Cun Wang; Guang-Zhi Jin; Hao-Jie Jin; Wen-Xin Qin
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

Review 3.  WNK kinases and renal sodium transport in health and disease: an integrated view.

Authors:  James A McCormick; Chao-Ling Yang; David H Ellison
Journal:  Hypertension       Date:  2008-01-22       Impact factor: 10.190

4.  LINGO-1 interacts with WNK1 to regulate nogo-induced inhibition of neurite extension.

Authors:  Zhaohuan Zhang; Xiaohui Xu; Yong Zhang; Jianfeng Zhou; Zhongwang Yu; Cheng He
Journal:  J Biol Chem       Date:  2009-04-10       Impact factor: 5.157

Review 5.  WNK kinases and blood pressure control.

Authors:  Staci L Deaton; Samarpita Sengupta; Melanie H Cobb
Journal:  Curr Hypertens Rep       Date:  2009-12       Impact factor: 5.369

6.  WNK1 is required for mitosis and abscission.

Authors:  Szu-wei Tu; Abhijit Bugde; Katherine Luby-Phelps; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

7.  C. elegans STK39/SPAK ortholog-mediated inhibition of ClC anion channel activity is regulated by WNK-independent ERK kinase signaling.

Authors:  Rebecca A Falin; Hiroaki Miyazaki; Kevin Strange
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-15       Impact factor: 4.249

8.  ErbB targeting inhibitors repress cell migration of esophageal squamous cell carcinoma and adenocarcinoma cells by distinct signaling pathways.

Authors:  Christiane D Fichter; Verena Gudernatsch; Camilla M Przypadlo; Marie Follo; Gudula Schmidt; Martin Werner; Silke Lassmann
Journal:  J Mol Med (Berl)       Date:  2014-08-06       Impact factor: 4.599

Review 9.  Emerging roles for WNK kinases in cancer.

Authors:  Sónia Moniz; Peter Jordan
Journal:  Cell Mol Life Sci       Date:  2010-01-22       Impact factor: 9.261

10.  Mutations in the nervous system--specific HSN2 exon of WNK1 cause hereditary sensory neuropathy type II.

Authors:  Masoud Shekarabi; Nathalie Girard; Jean-Baptiste Rivière; Patrick Dion; Martin Houle; André Toulouse; Ronald G Lafrenière; Freya Vercauteren; Pascale Hince; Janet Laganiere; Daniel Rochefort; Laurence Faivre; Mark Samuels; Guy A Rouleau
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.